home / stock / hbp:cc / hbp:cc news

HBP:CC News and Press, Helix BioPharma Corp. From 03/20/24

Stock Information
Company Name: Helix BioPharma Corp.
Stock Symbol: HBP:CC
Market: TSXC
Menu
HBP:CC HBP:CC Quote HBP:CC Short HBP:CC News HBP:CC Articles HBP:CC Message Board
Get HBP:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
HBP:CC - Expected Canadian Company Earnings on Wednesday, March 20th, 2024

SQI Diagnostics Inc. (SQD.H:CA) is expected to report for quarter end 2023-12-31 Petrus Resources Ltd. (PRQ:CA) is expected to report $0.02 for Q4 2023 Pedro Resources Ltd (VBN:CNX) is expected to report for quarter end 2023-12-31 Americas Gold and Silver Corporation (USA:CA) is expec...
HBP:CC - Helix BioPharma Corp. Reports Voting Results

(TheNewswire) January 18, 2024 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its pr...

HBP:CC - Helix BioPharma Corp. Announces Fiscal 2024 First Quarter Results

(TheNewswire) Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in ...

HBP:CC - Expected Canadian Company Earnings on Wednesday, December 13th, 2023

VersaBank (VBNK:CA) is expected to report $0.44 for Q4 2023 Genesis Land Development Corp. (GDC:CA) is expected to report for Q2 2024 Aberdeen International Inc. (AAB:CA) is expected to report for Q1 2024 Crown Capital Partners Inc. (CRWN:CA) is expected to report for Q1 2024 Diam...
HBP:CC - Expected earnings - Helix BioPharma Corp.

Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024

HBP:CC - Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results

(TheNewswire) Toronto, Ontario - TheNewswire - October 27, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...

HBP:CC - Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

(TheNewswire) Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“ Helix ” or the “ Company ”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the...
HBP:CC - Helix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board Changes

(TheNewswire) Toronto, Ontario - TheNewswire - August 22, 2023 - Helix BioPharma Corp. (TSX:HBP) (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology...

HBP:CC - Helix BioPharma Corp. Announces Fiscal 2023 Third Quarter Results

(TheNewswire) Toronto, Ontario – TheNewswire – June 14, 2023 - Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of im...

HBP:CC - Helix Biopharma Corp. Announces Fiscal 2023 Second Quarter Results

(TheNewswire) Toronto, O N - TheNewswire - March 15, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of im...
Previous 10 Next 10